Tirzepatide Outcomes (SURMOUNT-1) The SURMOUNT-1 randomized clinical trial evaluated tirzepatide at three dose levels: 5 mg, 10 mg, and 15 mg weekly in adults with obesity
Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies
Its often ignored until it becomes disruptive
Ingredients Sodium, Palmitate, Sodium Cocate, Perfume, Aqua, Olive Oil peg 7 ester (Olive Leaf Extract), Sodium L-Pyroglutamate, Sodium Chloride, Sodium Lactate, Tocopheryl Acetate (Vitamin E), Etidronic Acid, Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate, Kojic Dipalmitate 2% L glutathione, Arbutin, Niacinamide, Vitamin C, TiO2